| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5578737 | Journal of Pain and Symptom Management | 2017 | 28 Pages |
Abstract
Patients continue to receive medications that are not prescribed as symptomatic treatment despite having a LLE. Very few rigorous studies have been conducted on minimizing preventive medications in patients with LLE, and expert opinion varies on medication optimization at the end of life. A consensus guideline that addresses this gap is of paramount importance.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Arjun PhD, Patsy PhD, Debra BPharm, Lisa M. PhD,